Crossmark

Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid

Crossref DOI link: https://doi.org/10.1016/j.abd.2024.04.012

Published Print: 2025-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Liang, Guirong https://orcid.org/0009-0000-9414-2891
Qian, Hua https://orcid.org/0009-0000-7085-9388
Sun, Chao https://orcid.org/0000-0002-4585-3344
Zhang, Hanmei https://orcid.org/0000-0001-9206-7330
Li, Zhiliang https://orcid.org/0000-0002-8560-9207
Li, Suo https://orcid.org/0000-0003-4764-5976
Jing, Ke https://orcid.org/0000-0001-5374-6955
Zhao, Chenjing https://orcid.org/0000-0002-3084-4891
Wang, Yuan https://orcid.org/0000-0002-4120-4873
Xiang, Ruiyu https://orcid.org/0000-0002-3211-8922
Li, Xiaoguang https://orcid.org/0000-0001-6419-5693
Feng, Suying https://orcid.org/0000-0002-1045-9064
License Information

Text and Data Mining valid from 2025-03-01

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2024-11-30
More Information

This article is maintained by: Elsevier

Article Title: Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2024.04.012

Content Type: article

Copyright: © 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.